首页 正文

LRP1 at the crossroads of Aβ clearance and therapeutic targeting in Alzheimer's disease

{{output}}
Alzheimer's disease (AD), characterized by progressive cognitive decline, memory impairment and behavioral disturbances, is the most common form of dementia, and no disease-modifying treatments are available to halt or slow its progression. Amyloid-beta (Aβ)... ...